146 related articles for article (PubMed ID: 10657538)
1. Diazepam and buspirone alter neuropeptide Y-like immunoreactivity in rat brain.
Krysiak R; Obuchowicz E; Herman ZS
Neuropeptides; 1999 Dec; 33(6):542-9. PubMed ID: 10657538
[TBL] [Abstract][Full Text] [Related]
2. Conditioned fear-induced changes in neuropeptide Y-like immunoreactivity in rats: the effect of diazepam and buspirone.
Krysiak R; Obuchowicz E; Herman ZS
Neuropeptides; 2000; 34(3-4):148-57. PubMed ID: 11021974
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Deo GS; Dandekar MP; Upadhya MA; Kokare DM; Subhedar NK
Brain Res; 2010 Mar; 1318():77-86. PubMed ID: 20059983
[TBL] [Abstract][Full Text] [Related]
4. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure.
Roy A; Pandey SC
Alcohol Clin Exp Res; 2002 Jun; 26(6):796-803. PubMed ID: 12068247
[TBL] [Abstract][Full Text] [Related]
5. Effect of substituted benzamides on feeding and hypothalamic neuropeptide Y-like immunoreactivity (NPY-LI) in rats.
Pawłowski J; Kmieciak-Kołada K; Obuchowicz E; Krysiak R; Herman ZS
Neuropeptides; 2001; 35(5-6):204-10. PubMed ID: 12030803
[TBL] [Abstract][Full Text] [Related]
6. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
7. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Gruber SH; Nomikos GG; Mathé AA
Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Taksande BG; Kotagale NR; Gawande DY; Bharne AP; Chopde CT; Kokare DM
Eur Neuropsychopharmacol; 2014 Jun; 24(6):955-63. PubMed ID: 24461723
[TBL] [Abstract][Full Text] [Related]
9. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
Westwood SC; Hanson GR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
[TBL] [Abstract][Full Text] [Related]
11. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
12. [The role of neuropeptide Y in anxiety].
Krysiak R; Obuchowicz E; Herman ZS
Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
Saurer TB; Ijames SG; Lysle DT
J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
[TBL] [Abstract][Full Text] [Related]
15. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression.
Jiménez-Vasquez PA; Diaz-Cabiale Z; Caberlotto L; Bellido I; Overstreet D; Fuxe K; Mathé AA
Eur Neuropsychopharmacol; 2007 Mar; 17(4):298-308. PubMed ID: 16904299
[TBL] [Abstract][Full Text] [Related]
16. Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression.
Caberlotto L; Jimenez P; Overstreet DH; Hurd YL; Mathé AA; Fuxe K
Neurosci Lett; 1999 Apr; 265(3):191-4. PubMed ID: 10327163
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine alters regional concentrations of neuropeptide Y and peptide YY in rat brain.
Sakai K; Maeda K; Okuyama S; Tanaka C
Biol Psychiatry; 1996 Dec; 40(12):1246-54. PubMed ID: 8959289
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion.
Chen SH; Cheung RT
J Biomed Sci; 2005; 12(2):267-78. PubMed ID: 15942706
[TBL] [Abstract][Full Text] [Related]
20. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
Kokare DM; Dandekar MP; Chopde CT; Subhedar N
Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
